RBCC: Talks with Potential Canadian Joint Venture Partners Exceed Expectations
Rainbow Coral Corp. (OTCBB: RBCC)
reports recent talks with possible joint venture partners were quite
productive and the company has high hopes it can work out agreements
with several prospects as it nears its much
anticipated Canadian rollout.
RBCC executives spoke with representatives of Canadian pharmacy groups
as well as medical and ethnic organizations (such as First Nations) in
the past several weeks. The talks centered on finding mutually
beneficial ways to collaborate on a range of topics, including substance
abuse treatment and personalized medicine initiatives.
「The preliminary discussions exceeded our expectations,」 said RBCC CEO
Kimberly Palmer. 「We found quite a lot of common ground and several
important areas where we can work together, particularly with
pharmaceutical firms. Should future talks prove as exciting and as
equally productive as these were, then we expect to make substantial
progress towards a highly successful Canadian rollout.」
The talks continue RBCC’s slate of achievements in Canada. RBCC earlier
announced it was nearing agreements to
deliver an effective alcohol abuse program.
Canada offers a promising market for RBCC. The country ranks second
only to the U.S. in per capita consumption of prescription opioids,
which often can be abused. Nearly 11
percent of Canadians suffer from alcohol or drug addiction.
RBCC is dedicated to delivering advanced medical research and
technologies to a booming global health marketplace. For more
information on RBCC’s initiatives, please visit www.rainbowbiosciences.com.
About Rainbow Biosciences
Rainbow
Biosciences, LLC, is a wholly owned subsidiary of Rainbow Coral
Corp. (RBCC).
The Company continually seeks out new partnerships with biotechnology
developers to deliver profitable new medical technologies and
innovations. For more information on our growth-oriented business
initiatives, please visit www.RainbowBioSciences.com.
For investment information and performance data on the Company, please
visit www.RainbowBioSciences.com/investors.html.
Notice Regarding Forward-Looking Statements
Safe Harbor Statement under the Private Securities Litigation Reform
Act of 1995: This news release contains forward-looking information
within the meaning of Section 27A of the Securities Act of 1933, as
amended, and Section 21E of the Securities Exchange Act of 1934, as
amended, including statements that include the words "believes,"
"expects," "anticipate" or similar expressions. Such forward-looking
statements involve known and unknown risks, uncertainties and other
factors that may cause the actual results, performance or achievements
of the Company to differ materially from those expressed or implied by
such forward-looking statements. In addition, description of anyone's
past success, either financial or strategic, is no guarantee of future
success. This news release speaks as of the date first set forth above
and the Company assumes no responsibility to update the information
included herein for events occurring after the date hereof.
View source version on businesswire.com: http://www.businesswire.com/news/home/20151001005247/en/
Rainbow Coral Corp.
Kimberly Palmer, 702-940-2345
President
and CEO
info@rainbowcoral.com
Copyright Business Wire 2015Business WireOctober 1, 2015 - 5:00 AM EDTNews by QuoteMediawww.quotemedia.com
關注同花順財經（ths518），獲取更多機會
責任編輯：pm